P32 SODIUM PHOSPHATE injection, suspension

P32 Sodium Phosphate by

Drug Labeling and Warnings

P32 Sodium Phosphate by is a Prescription medication manufactured, distributed, or labeled by AnazaoHealth Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DESCRIPTION

AnazaoHealth’s compounded P32 Chromic Phosphate is supplied as a sterile, nonpyrogenic aqueous solution. It contains 30 % dextrose solution, 1 mg sodium acetate, 2 % benzyl alcohol added as a preservative. Sodium hydroxide or hydrochloric acid may be added for pH adjustment.

INDICATIONS AND USAGE

P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections.

Mechanism of Action

Radioactive phosphorous works by local irradiation by beta emission.

CONTRAINDICATIONS

P32 sodium phosphate should not be used in the presence of ulcerative tumors.

WARNINGS

Not for intravascular injection.

DOSAGE AND ADMINISTRATION

Shake the vial well before injection.

For intraperitoneal instillation, administer 10-20 mCi

For intrapleural instillation, administer 6 to 12 mCi

Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm.

DECAY CHART

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Figure 1

INGREDIENTS AND APPEARANCE

P32 SODIUM PHOSPHATE 
p32 sodium phosphate injection, suspension

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 51808-127
Route of Administration	INTRA-ARTICULAR, INTRAPERITONEAL, INTERSTITIAL, INTRAPLEURAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PHOSPHORUS P-32 (UNII: 690284A407) (PHOSPHORUS P-32 - UNII:690284A407)	PHOSPHORUS P-32	5 mCi  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
DEXTROSE (UNII: IY9XDZ35W2)	0.3 g  in 1 mL
BENZYL ALCOHOL (UNII: LKG8494WBH)	0.02 mL  in 1 mL
SODIUM ACETATE (UNII: 4550K0SC9B)	1 mg  in 1 mL

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 51808-127-01	3 mL in 1 VIAL

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		06/19/2012

Labeler - AnazaoHealth Corporation (011038762)

Establishment
Name	Address	ID/FEI	Business Operations
AnazaoHealth Corporation		011038762	MANUFACTURE(51808-127)